CHMP backs proposed biosimilars of pegfilgrastimSeptember 24, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
Sequencing informs prognosis after HSCT in MDSSeptember 18, 2018AnemiaTransplantationMyelodysplastic Syndrome
AMP publishes report on DNA variants in CMNsAugust 23, 2018CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic SyndromeCML
Partial hold placed on trial of drug for AML, MDSAugust 18, 2018AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Auto-HSCT linked to higher AML, MDS riskAugust 14, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantationAMLMyelodysplastic Syndrome
Familial risk of myeloid malignanciesAugust 13, 2018CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic SyndromeCML
FA pathway key to DNA repair after CRISPR cuttingAugust 1, 2018AnemiaThrombosisRelated IssuesBleeding Disorders
CHMP supports expanded approval for epoetin alfa productsJuly 31, 2018AnemiaPharmacyMyelodysplastic Syndrome
CHMP backs 2 biosimilar pegfilgrastim productsJuly 31, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
Study could change treatment of MLSM7July 27, 2018AnemiaLeukemia, Myelodysplasia, TransplantationTransplantationAMLMyelodysplastic Syndrome
